Latest News and Press Releases

Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years, AAIC 2025 Presentation Findings Show

Neurogen Biomarking to present novel data on at-home p-tau 217 testing for Alzheimer’s disease at Alzheimer’s Association International Conference® 2025

SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- In a new study, researchers at the Federal University of Rio de Janeiro in Brazil found that computerized brain exercises drove significant gains not...

Investigator-initiated clinical trial of SLT (CognivAiDTM) for mild cognitive impairment (MCI) reported significant improvement in key cognitive domains.

New York, United States , April 20, 2023 (GLOBE NEWSWIRE) -- The Global Mild Cognitive Impairment (MCI) Market Size is To Grow from USD 2.1 Billion in 2022 to USD 3.5 Billion by 2032, at a Compound...

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to...

SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Researchers at Yale published positive results from a pilot study of a novel combination therapy in patients with Mild Cognitive Impairment related...

SAN FRANCISCO, March 16, 2020 (GLOBE NEWSWIRE) -- A newly published imaging study in NeuroImage from researchers at the University of Rochester has shown that brain training drove improvements in...

MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...

MONMOUTH JUNCTION, NJ--(Marketwired - September 26, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, reported today that...